News & Press

26. November 2025

Press Release | Dynamic42 launches Tumor Microenvironment Kit to advance complex in vitro cancer research

Dynamic42 GmbH announces the market launch of its Tumor Microenvironment (TME) Kit. The new product enables the creation of perfused 3D tumor models that reproduce the complexity of the human tumor microenvironment.

15. September 2025

Dr. Franziska Hausig-Punke joins Dynamic42 as Sales Manager

Dr. Franziska Hausig-Punke becomes our new Sales Manager, bringing deep industry experience to expand our presence in Life Sciences and Pharma.

15. September 2025

Dynamic42 Strengthens Team with Continued Contributions of Amélie Paillereau and Tim Kaden

We are thrilled to announce that both Amélie Paillereau and Tim Kaden will continue their professional journeys with Dynamic42 and will further strengthen our team with their expertise and dedication.

15. September 2025

Dr. Lara Thieme joins Dynamic42 as Senior Scientist

Dr. Lara Thieme strengthens our R&D as Senior Scientist, focusing on biofilm infections and cystic fibrosis-on-chip models.

15. September 2025

Dr. Susann Hartung joins Dynamic42 to support Customer and Order Management

Dr. Susann Hartung joins Dynamic42 to support Customer and Order Management

16. May 2025

Marty Steiger joins Dynamic42 as Applications Specialist

We are delighted to announce that Marty Steiger has recently joined Dynamic42 as a applications specialist.

30. April 2025

Press Release | Ohio Lumex Named Exclusive U.S. Distributor for Dynamic42’s Advanced Organ-on-Chip Technology

Ohio Lumex, a recognized leader in analytical solutions, is proud to announce a new partnership with German biotechnology company Dynamic42. Effective immediately, Ohio Lumex will serve as the exclusive distributor of Dynamic42’s innovative organ-on-chip technology in the United States.

6. March 2025

Press Release | Tumour-on-chip model supports preclinical drug development on pancreatic cancer

Dynamic42 and Heinrich Heine University have developed a tumour-on-a-chip model that replicates the microenvironment of pancreatic ductal adenocarcinoma (PDAC). This 3D model allows for realistic drug testing and could accelerate the development of personalized therapies.

19. February 2025

Press Release | Dynamic42 and research partners present three-organ system to reduce animal testing

Dynamic42, in collaboration with ESQlabs, Bayer, and the Placenta Lab, has developed an innovative three-organ system with the potential to reduce animal testing in pharmaceutical research.

5. February 2025

Dynamic42 interviewed by the OTZ

We were interviewed by the Ostthüringer Zeitung on the subject of animal-free research.

22. November 2024

Press Release | New e-learning platform for learning Organ-on-chip technology as a replacement for animal testing

Dynamic42 has launched the "Online Academy" for learning Organ-on-Chip technology as an alternative to animal testing.

3. September 2024

Cancer, rheumatism, asthma: organ-on-chip models highly relevant for preclinical testing of therapeutic antibodies

Improving people's lives with innovative technologies. This was the goal that Jena-based Dynamic42 had in mind 18 months ago when they launched a project - funded as part of the Sanofi iDEA-iTECH Award Program.

14. August 2024

ATHANA alliance for antifungal therapy approaches – First strategy workshop

The RUBIN alliance “ATHANA” met for their first strategy workshop one year after the project kicked off in summer last year.

11. July 2024

Amélie Marie Paillereau joins Dynamic42 as Master Student funded by the Thuringia and European Social Fund Plus

We are excited to welcome Amélie Marie Paillereau to the Dynamic42 science team. Amélie started in April with us for a 12-month-long Master thesis, focusing on perfused breast and pancreatic cancer-on-chip models to study the impact of the tumor microenvironment on immune cell invasion.

6. June 2024

Joanna Nowacka joins Dynamic42 as Lead for Stem Cell Model Development

We are delighted to announce that Joanna Nowacka has joined Dynamic42 as Lead for Stem Cell Model Development.

5. June 2024

Press Release | Biotech company Dynamic42 launches open platform for organ model development

Dynamic42 has launched the "DynamicOrgan System", an open, flexible, and cost-effective organ-on-chip platform for lab use.

27. March 2024

Mari Kakihara joins Dynamic42 to support Finance and Controlling

We are excited to announce that Mari Kakihara has joined us recently to support Finance and Controlling.

21. March 2024

Press Release | The Dynamic42 3D intestinal chip model takes research of fungal infections to a new level

Dynamic42 GmbH has developed an intestine-on-chip candidiasis model that allows for the quantification of the infection process.

30. January 2024

Dr. Japhette Kembou-Ringert joins Dynamic42 as Senior Scientist

We are excited to announce that Japhette Kembou-Ringert has joined us at the beginning of this year to support our lab team.

25. January 2024

Press Release | Biotechs Dynamic42 and Biopredic join for strategic Marketing agreement

Organ-on-chip specialist Dynamic42 GmbH and Biopredic, manufacturer of assay systems for research, announce a strategic Marketing agreement.

17. October 2023

Noreen Schuck joins Dynamic42 as new lab assistant

We are excited to announce that Noreen Schuck has joined us at the beginning of October to support our lab team.

12. October 2023

First network meeting of the federal network 3R

The first 3R network meeting, organized by the Federal Ministry of Education and Research (BMBF) in Berlin, brought together various experts to discuss current developments, perspectives, and challenges in 3R research.

5. September 2023

Dr. Juliane Fischer joins Dynamic42 as Marketing Manager

We are delighted to announce that Dr. Juliane Fischer has joined our team and will from now on heading all Marketing efforts at Dynamic42.

29. August 2023

Daria and Sophie join the Dynamic42 lab team as permanent members

Following their Master's studies, Daria and Sophie join our lab team as research assistants.

5. July 2023

Press Release | BMBF provides Millions in Funding for Thuringia’s ATHANA Alliance

The RUBIN Alliance "ATHANA" (antifungal therapy approaches with nanoparticle-based targeting of drugs) is developing innovative therapeutic approaches for the treatment of infectious diseases, in particular fungal infections.

13. June 2023

Press Release | Dynamic42 raises mid-seven-figure investment in Series A financing round

Innovative organ-on-chip specialist Dynamic42 GmbH has closed a mid-seven-figure financing round.

17. April 2023

Press Release | Dynamic42 develops new generation of biotech chips for organ-on-chip technology

BC003: The special feature of the new chip is the spatial design with three culture chambers. This enables the cultivation of complex, three-dimensional tissue cultures.

7. March 2023

Press Release | New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software.

13. February 2023

Press Release | Dynamic42 Academy

Jena-based biotech company passes on expertise on future organ-on-chip technology to research institutions and companies

1. July 2022

Dynamic42 in the Wirtschaftspiegel

We were featured as a member of medways e.V. in Wirtschaftsspiegel.

28. March 2022

Interview with the magazine “Laborjournal”

In an interview with the trade journal "Laborjournal", our managing directors explain how the Dynamic42 biotech chips work and how the "mini-organs" used contribute to reducing animal experiments.

18. March 2022

Dynamic42 Organ-On-Chip Technology in MED Engineering

An article in the MED Engineering journal explained the potential of our "mini organs" from the laboratory for drug and food testing.

6. January 2022

Founder interview

Exciting answers to exciting questions: We were interviewed by bionity and analytica-world. Read it now!

24. September 2021

We are Start-Up of the Week!

Read the interview with Thomas Stölzel in WirtschaftsWoche.

4. August 2021

Organ-on-Chip in food analysis

Find out how our biotech chips are used in food analysis!

23. February 2021

Dynamic42 interviewed by MDR

You want to know why we are called "Dynamic42"? Take a look at our feature on MDR Thüringen!

16. November 2020

Dynamic42 interviewed by OTZ

At the award ceremony for the XXIII Thuringian Innovation Prize, we were interviewed about our development for the Ostthüringer Zeitung newspaper.

6. April 2020

Jena-based biotechnology company “Dynamic42” raises seven-figure investment

Dynamic42 GmbH has closed a seven-figure start-up financing round - Read more about

4. December 2019

Dynamic42 participates in EU project to develop innovative model systems for the evaluation of immunomodulatory therapeutics

We participate in the EU project to develop innovative model systems for the evaluation of immunomodulatory therapeutics.

15. July 2019

Dynamic42 GmbH receives seed financing

The first seed financing in the six-figure range was closed in early summer 2019.

7. December 2018

Thuringian Founder’s Award – Dynamic42 GmbH honoured

We were awarded the Thuringian Founder's Prize 2018! We would like to thank everyone who made this possible for us!

5. November 2018

Dynamic42 at the Medica in Düsseldorf

We are at Medica in Düsseldorf - Come by and meet us!

19. October 2018

XXI Thuringian Innovation Award – Online Voting

Find out how our biotech chips are used in food analysis!

15. October 2018

EY Public Value Award – Dynamic42 GmbH honoured

At the EY Public Value Award 2018, Dynamic42 GmbH was awarded the audience prize.